Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 8
Submit an article Journal homepage
4,513
Views
7
CrossRef citations to date
0
Altmetric
Rheumatology

Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan

Der-Yuan Chena Rheumatology and Immunology Center, Department of Medicine, China Medical University Hospital, Taichung, Taiwan; ;b Translation Medicine Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; ;c School of Medicine, China Medical University, Taichung, Taiwan;
,
Ping-Ning Hsud Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan; Correspondence[email protected]
,
Chao-Hsiun Tange School of Health Care Administration, Taipei Medical University, Taipei, Taiwan;
,
Lindsay Claxtonf York Health Economics Consortium, York, UK; ORCID Iconhttps://orcid.org/0000-0002-1795-7568
ORCID Icon,
Satish Vallurig Pfizer Inc, Collegeville, PA, USA;
&
Robert A. Gerberh Pfizer Inc, Groton, CT, USA
Pages 777-787 | Received 14 Aug 2018, Accepted 01 Apr 2019, Published online: 15 May 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.